Recent Updates
Recently added Catalysts
KPTI Neutral Sentiment

Karyopharm to Report First Quarter 2025 Financial Results on May 12, 2025

Thursday, May 8, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Karyopharm Therapeutics Inc. has announced that it will report its financial results for the first quarter of 2025 on May 12, 2025. A conference call is scheduled to take place at 4:30 p.m. ET on the same day, during which the management team will discuss the financial results and provide additional company updates. Investors can access the call via a dedicated phone line or through an audio webcast on the company's website.
Price reaction · baseline $6.11 (2025-05-07 close) · hit after-hours · 1 other KPTI headline(s) in the window, move may be shared
day 0 close
+0.7%

Market Sentiment Analysis

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+105%
120-day peak, hindsight
Typical move
15.1%
average across 5 past catalysts
Cash runway
~8 mo
Medium dilution risk
Lead asset
Selinexor
Phase 2 · Acute Myeloid Leukemia (AML)

Full Press Release Details

-- Conference Call Scheduled for Monday, May 12, 2025, at 4:30 p.m. ET --
NEWTON, Mass., May 8, 2025 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced it will report first quarter 2025 financial results on Monday, May 12, 2025. Karyopharm's management team will host a conference call and audio webcast at 4:30 p.m. ET on Monday, May 12, 2025, to discuss the financial results and other company updates.
To access the conference call, please dial (800) 836-8184 (local) or (646) 357-8785 (international) at least 10 minutes prior to the start time and ask to be joined into the Karyopharm Therapeutics call. A live audio webcast of the call, along with accompanying slides, will be available under "Events & Presentations" in the Investor section of the Company's website, http://investors.karyopharm.com/events-presentations. An archived webcast will be available on the Company's website approximately two hours after the event.
About Karyopharm Therapeutics
XPOVIO® and NEXPOVIO® are registered trademarks of Karyopharm Therapeutics Inc.

Frequently Asked Questions

When will Karyopharm report its Q1 2025 financial results?

Karyopharm will report its Q1 2025 financial results on May 12, 2025.

What time is the Karyopharm conference call scheduled?

The conference call is scheduled for 4:30 p.m. ET on May 12, 2025.

How can I access the Karyopharm conference call?

Call (800) 836-8184 or (646) 357-8785 to join the Karyopharm call.

Will there be a webcast of the conference call?

Yes, a live webcast with slides will be available on Karyopharm's website.

When will the archived webcast be available?

The archived webcast will be available approximately two hours after the event.

ShareAdd on Google
Tags: KPTI Viatris Investor Conferences Healthcare Karyopharm financial results quarterly report conference call
Last updated: May 8, 2025

Biotech snapshot

Cash runway
$65M liquidity · $8M/mo burn
~8 mo
Medium dilution risk
Lead asset
SelinexorPhase 2
Acute Myeloid Leukemia (AML) →

Catalyst track record

+105%
best trade around KPTI's most recent catalyst

Peak hindsight return over a 120-day window, across 5 tracked FDA/PDUFA catalysts for KPTI.

See every catalyst's timing & PoA →